KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Travere Therapeutics (TVTX) Prepaid Assets (2016 - 2025)

Travere Therapeutics (TVTX) has disclosed Prepaid Assets for 13 consecutive years, with $28.8 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Prepaid Assets rose 126.72% year-over-year to $28.8 million, compared with a TTM value of $28.8 million through Dec 2025, up 126.72%, and an annual FY2025 reading of $28.8 million, up 126.72% over the prior year.
  • Prepaid Assets was $28.8 million for Q4 2025 at Travere Therapeutics, up from $28.0 million in the prior quarter.
  • Across five years, Prepaid Assets topped out at $28.8 million in Q4 2025 and bottomed at $6.5 million in Q1 2022.
  • Average Prepaid Assets over 5 years is $13.4 million, with a median of $12.7 million recorded in 2024.
  • The sharpest move saw Prepaid Assets soared 132.7% in 2023, then plummeted 34.39% in 2024.
  • Year by year, Prepaid Assets stood at $6.7 million in 2021, then surged by 79.12% to $12.0 million in 2022, then soared by 60.68% to $19.3 million in 2023, then tumbled by 34.39% to $12.7 million in 2024, then surged by 126.72% to $28.8 million in 2025.
  • Business Quant data shows Prepaid Assets for TVTX at $28.8 million in Q4 2025, $28.0 million in Q3 2025, and $17.2 million in Q2 2025.